Clinical trial
A Randomized Controlled Trial of the Effect of IV Iron on Proteinuria in Non-Dialysis Chronic Kidney Disease Patients
NCT00534144 is registered in ClinicalTrials.gov with Watson Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of the Effect of IV Iron on Proteinuria in Non-Dialysis Chronic Kidney Disease Patients
- Lead sponsor
- Watson Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- November 30, 2008
- Enrollment
- 74 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.